IL117980A - Triazolone derivatives their preparation and pharmaceutical compositions containing them useful for the treatment of hyperlipidemia - Google Patents
Triazolone derivatives their preparation and pharmaceutical compositions containing them useful for the treatment of hyperlipidemiaInfo
- Publication number
- IL117980A IL117980A IL11798096A IL11798096A IL117980A IL 117980 A IL117980 A IL 117980A IL 11798096 A IL11798096 A IL 11798096A IL 11798096 A IL11798096 A IL 11798096A IL 117980 A IL117980 A IL 117980A
- Authority
- IL
- Israel
- Prior art keywords
- 6alkyl
- hyperlipidemia
- preparation
- treatment
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95201010 | 1995-04-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL117980A0 IL117980A0 (en) | 1996-08-04 |
| IL117980A true IL117980A (en) | 2000-02-17 |
Family
ID=8220206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11798096A IL117980A (en) | 1995-04-20 | 1996-04-19 | Triazolone derivatives their preparation and pharmaceutical compositions containing them useful for the treatment of hyperlipidemia |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US5922718A (cs) |
| EP (1) | EP0871626B1 (cs) |
| JP (1) | JP3782455B2 (cs) |
| KR (1) | KR100413219B1 (cs) |
| CN (1) | CN1076727C (cs) |
| AT (1) | ATE208386T1 (cs) |
| AU (1) | AU699313B2 (cs) |
| CA (1) | CA2217632A1 (cs) |
| CZ (1) | CZ291737B6 (cs) |
| DE (1) | DE69616825T2 (cs) |
| DK (1) | DK0871626T3 (cs) |
| ES (1) | ES2167555T3 (cs) |
| HK (1) | HK1012186A1 (cs) |
| HU (1) | HUP9801056A3 (cs) |
| IL (1) | IL117980A (cs) |
| NO (1) | NO312415B1 (cs) |
| NZ (1) | NZ305869A (cs) |
| PL (1) | PL183737B1 (cs) |
| PT (1) | PT871626E (cs) |
| TW (1) | TW457240B (cs) |
| WO (1) | WO1996033193A1 (cs) |
| ZA (1) | ZA963152B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL163846A0 (en) | 2002-03-01 | 2005-12-18 | Univ South Florida | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| CN100360117C (zh) | 2002-06-21 | 2008-01-09 | 转化医药公司 | 具有提高的溶出度的药物组合物 |
| WO2004111652A1 (en) | 2003-06-19 | 2004-12-23 | Applied Research Systems Ars Holding N.V. | Use of prion conversion modulating agents |
| EP1725870A1 (en) * | 2004-03-18 | 2006-11-29 | Applied Research Systems ARS Holding N.V. | Anti-lipid rafts antibodies |
| EP1742941A1 (en) * | 2004-04-22 | 2007-01-17 | Transform Pharmaceuticals, Inc. | Novel saperconazole crystalline forms and related processes, pharmaceutical compositions and methods |
| WO2006129193A2 (en) * | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| PT3003038T (pt) | 2013-06-07 | 2019-11-19 | Scripps Research Inst | Derivados 2h-1,2,3-triazólicos como inibidores de fibrose |
| EP3169343B1 (en) | 2014-07-15 | 2020-03-25 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Isolated polypeptides of cd44 and uses thereof |
| JP6706023B2 (ja) | 2014-12-10 | 2020-06-03 | ザ・スクリップス・リサーチ・インスティテュート | 線維症の小分子阻害剤 |
| AU2018251415B2 (en) | 2017-04-11 | 2021-08-05 | Mitsui Chemicals Crop & Life Solutions, Inc. | Pyridone compounds and agricultural and horticultural fungicides containing the same as active ingredients |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3936470A (en) * | 1975-01-27 | 1976-02-03 | Janssen Pharmaceutica N.V. | 1,3-Dioxolan-2-ylmethylimidazoles |
| US4101664A (en) * | 1975-10-06 | 1978-07-18 | Janssen Pharmaceutica N.V. | 1-(2-Ar-4-aryloxymethyl-1,3-dioxolan-2-ylmethyl)-imidazoles |
| US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| US4321272A (en) * | 1980-08-25 | 1982-03-23 | Syntex (U.S.A.) Inc. | Derivatives of substituted N-alkylimidazoles |
| DE3144318A1 (de) * | 1981-11-07 | 1983-05-19 | Bayer Ag, 5090 Leverkusen | 2-imidazolylmethyl-2-phenyl-1, 3-dioxolane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
| US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| US4916134A (en) * | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
| NZ223799A (en) * | 1987-03-25 | 1989-12-21 | Janssen Pharmaceutica Nv | Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions |
| PT741737E (pt) * | 1994-01-24 | 2000-04-28 | Janssen Pharmaceutica Nv | Antifungicos do tipo azole soluveis em agua |
-
1996
- 1996-03-22 TW TW085103449A patent/TW457240B/zh not_active IP Right Cessation
- 1996-04-12 DK DK96910968T patent/DK0871626T3/da active
- 1996-04-12 US US08/930,847 patent/US5922718A/en not_active Expired - Fee Related
- 1996-04-12 DE DE69616825T patent/DE69616825T2/de not_active Expired - Fee Related
- 1996-04-12 KR KR1019970706751A patent/KR100413219B1/ko not_active IP Right Cessation
- 1996-04-12 EP EP96910968A patent/EP0871626B1/en not_active Expired - Lifetime
- 1996-04-12 NZ NZ305869A patent/NZ305869A/en unknown
- 1996-04-12 WO PCT/EP1996/001585 patent/WO1996033193A1/en active IP Right Grant
- 1996-04-12 AU AU53998/96A patent/AU699313B2/en not_active Ceased
- 1996-04-12 CA CA002217632A patent/CA2217632A1/en not_active Abandoned
- 1996-04-12 ES ES96910968T patent/ES2167555T3/es not_active Expired - Lifetime
- 1996-04-12 CN CN96193235A patent/CN1076727C/zh not_active Expired - Fee Related
- 1996-04-12 HU HU9801056A patent/HUP9801056A3/hu unknown
- 1996-04-12 CZ CZ19973288A patent/CZ291737B6/cs not_active IP Right Cessation
- 1996-04-12 PL PL96322872A patent/PL183737B1/pl not_active IP Right Cessation
- 1996-04-12 AT AT96910968T patent/ATE208386T1/de not_active IP Right Cessation
- 1996-04-12 PT PT96910968T patent/PT871626E/pt unknown
- 1996-04-12 JP JP53146096A patent/JP3782455B2/ja not_active Expired - Fee Related
- 1996-04-19 IL IL11798096A patent/IL117980A/xx not_active IP Right Cessation
- 1996-04-19 ZA ZA9603152A patent/ZA963152B/xx unknown
-
1997
- 1997-10-10 NO NO19974690A patent/NO312415B1/no unknown
-
1998
- 1998-12-15 HK HK98113362A patent/HK1012186A1/xx not_active IP Right Cessation
-
1999
- 1999-02-17 US US09/251,989 patent/US6197972B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK0871626T3 (da) | 2002-02-25 |
| ES2167555T3 (es) | 2002-05-16 |
| NZ305869A (en) | 1998-08-26 |
| KR100413219B1 (ko) | 2004-05-31 |
| ATE208386T1 (de) | 2001-11-15 |
| ZA963152B (en) | 1997-10-20 |
| JPH11503739A (ja) | 1999-03-30 |
| EP0871626A1 (en) | 1998-10-21 |
| HUP9801056A2 (hu) | 1999-06-28 |
| NO312415B1 (no) | 2002-05-06 |
| PT871626E (pt) | 2002-04-29 |
| IL117980A0 (en) | 1996-08-04 |
| CA2217632A1 (en) | 1996-10-24 |
| CN1181079A (zh) | 1998-05-06 |
| PL322872A1 (en) | 1998-03-02 |
| AU699313B2 (en) | 1998-12-03 |
| NO974690L (no) | 1997-10-10 |
| US6197972B1 (en) | 2001-03-06 |
| JP3782455B2 (ja) | 2006-06-07 |
| AU5399896A (en) | 1996-11-07 |
| WO1996033193A1 (en) | 1996-10-24 |
| CN1076727C (zh) | 2001-12-26 |
| DE69616825T2 (de) | 2002-06-27 |
| NO974690D0 (no) | 1997-10-10 |
| HK1012186A1 (en) | 1999-07-30 |
| US5922718A (en) | 1999-07-13 |
| KR19980703346A (ko) | 1998-10-15 |
| PL183737B1 (pl) | 2002-07-31 |
| CZ291737B6 (cs) | 2003-05-14 |
| DE69616825D1 (en) | 2001-12-13 |
| EP0871626B1 (en) | 2001-11-07 |
| HUP9801056A3 (en) | 1999-09-28 |
| CZ328897A3 (cs) | 1998-01-14 |
| TW457240B (en) | 2001-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY102866A (en) | Amide derivatives. | |
| HUP0201646A2 (hu) | Új alfa-aminosav vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények | |
| NO922147D0 (no) | Heterocykliske derivater | |
| MY101359A (en) | 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation | |
| HU900064D0 (en) | Process for preparation of new 2-amino pyrimidinone-derivatives | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| CA2203274A1 (en) | Apolipoprotein-b synthesis inhibitors | |
| MY132062A (en) | Apolipoprotein-b synthesis inhibitors | |
| IL117980A (en) | Triazolone derivatives their preparation and pharmaceutical compositions containing them useful for the treatment of hyperlipidemia | |
| HUP0104308A2 (hu) | Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek | |
| DE69323322D1 (de) | Verwendung dimethylbenzofuran und dimethylbenzopyran derivate als 5-ht3 antagoniste | |
| HUP0402515A2 (hu) | Szubsztituált új N-[4-(1H-imidazol-1-il)-2-fluor-fenil]-3-(trifluor-metil)-1H-pirazol-5-karboxamidok Xa faktor inhibitorok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| CA2212893A1 (en) | Prokinetic oxadiazoles | |
| AU5899296A (en) | (2-morpholinylmethyl)benzamide derivatives | |
| FI872997A (fi) | Amidderivat. | |
| FI962120A0 (fi) | Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominaisuudet | |
| MX9704667A (es) | 6-[triazolil[3-trifluorometil)fenil]metil]-2-quinolinonas y quinolinotionas. | |
| JO1648B1 (en) | Nitrogen compounds | |
| JO1697B1 (en) | Pyridine derivatives | |
| JO1720B1 (en) | Heterocyclic derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |